C. Varette

849 total citations
23 papers, 667 citations indexed

About

C. Varette is a scholar working on Oncology, Surgery and Reproductive Medicine. According to data from OpenAlex, C. Varette has authored 23 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Surgery and 7 papers in Reproductive Medicine. Recurrent topics in C. Varette's work include Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). C. Varette is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). C. Varette collaborates with scholars based in France, Australia and Belgium. C. Varette's co-authors include M Krulik, Christophe Louvet, Aimery de Gramont, J. Vignoud, Éric Raymond, Thierry André, Christophe Tournigand, S. Moreau, N Le Bail and L. Kayitalire and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and European Journal of Cancer.

In The Last Decade

C. Varette

22 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Varette France 10 436 189 181 153 115 23 667
Jean Pierre Lotz France 10 366 0.8× 101 0.5× 127 0.7× 69 0.5× 47 0.4× 21 566
D. Lepillé France 9 198 0.5× 133 0.7× 104 0.6× 94 0.6× 87 0.8× 12 360
P Dufour France 8 385 0.9× 103 0.5× 112 0.6× 32 0.2× 60 0.5× 24 532
P. Comella Italy 19 656 1.5× 143 0.8× 378 2.1× 37 0.2× 82 0.7× 65 829
Daniela Garavaglia Italy 9 157 0.4× 75 0.4× 103 0.6× 131 0.9× 109 0.9× 9 588
Edmonson Jh United States 12 250 0.6× 100 0.5× 160 0.9× 198 1.3× 6 0.1× 27 566
Jennifer R. Scudiere United States 10 261 0.6× 325 1.7× 172 1.0× 37 0.2× 18 0.2× 19 559
David D. Gibbs New Zealand 8 213 0.5× 60 0.3× 173 1.0× 34 0.2× 24 0.2× 15 514
J Genollá Spain 11 198 0.5× 89 0.5× 82 0.5× 36 0.2× 52 0.5× 37 447
Karen Theilade Denmark 6 160 0.4× 146 0.8× 54 0.3× 201 1.3× 7 0.1× 7 388

Countries citing papers authored by C. Varette

Since Specialization
Citations

This map shows the geographic impact of C. Varette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Varette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Varette more than expected).

Fields of papers citing papers by C. Varette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Varette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Varette. The network helps show where C. Varette may publish in the future.

Co-authorship network of co-authors of C. Varette

This figure shows the co-authorship network connecting the top 25 collaborators of C. Varette. A scholar is included among the top collaborators of C. Varette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Varette. C. Varette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gligorov, Joseph, Laurent Bastit, D. Lepillé, et al.. (2010). Prevalence and Treatment Management of Oropharyngeal Candidiasis in Cancer Patients: Results of the French Candidoscope Study. International Journal of Radiation Oncology*Biology*Physics. 80(2). 532–539. 27 indexed citations
2.
Hebbar, Mohamed, Christophe Tournigand, Gérard Lledo, et al.. (2006). Phase II Trial Alternating FOLFOX-6 and FOLFIRI Regimens in Second-Line Therapy of Patients with Metastatic Colorectal Cancer (FIREFOX Study). Cancer Investigation. 24(2). 154–159. 24 indexed citations
3.
Friedländer, Michael, Michael Millward, David Bell, et al.. (1998). A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer. Annals of Oncology. 9(12). 1343–1345. 123 indexed citations
4.
Gramont, Aimery de, J. Vignoud, Christophe Tournigand, et al.. (1997). Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer. European Journal of Cancer. 33(2). 214–219. 311 indexed citations
5.
Tourani, J.M., Virginie Lucas, Didier Mayeur, et al.. (1996). Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Annals of Oncology. 7(5). 525–528. 28 indexed citations
6.
Louvet, C., et al.. (1996). Dual modulation of 5-fluorouracil with folinic acid and hydroxyurea in metastatic colorectal cancer.. PubMed. 6(2). 97–101. 12 indexed citations
7.
Raymond, Éric, C. Louvet, M Debray, et al.. (1995). Extravasation de paclitaxel (Taxol®). La Revue de Médecine Interne. 16(2). 141–142. 6 indexed citations
8.
Smadja, Nicole, et al.. (1995). Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques. British Journal of Haematology. 90(3). 619–624. 36 indexed citations
9.
Louvet, C., Aimery de Gramont, K. Beerblock, et al.. (1995). 557 Hydroxyurea, folinic acid, 5FU bolus and infusion (HLFP regimen) in advanced gastric cancer. European Journal of Cancer. 31. S119–S119. 1 indexed citations
10.
Louvet, Christophe, et al.. (1994). Découverte d'un adénocarcinome ovarien à l'occasion d'un accident vasculaire cérébral associé à une coagulopathie de consommation. La Revue de Médecine Interne. 15(1). 48–51. 1 indexed citations
11.
Louvet, C., Aimery de Gramont, K. Beerblock, et al.. (1993). Folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide in metastatic breast cancer. European Journal of Cancer. 29(13). 1835–1838. 2 indexed citations
12.
Gramont, Aimery de, et al.. (1993). Toxicité du lévamisole dans la chimiothérapie adjuvante du cancer colorectal. La Revue de Médecine Interne. 14(9). 821–824. 1 indexed citations
13.
Machover, D., Armand de Gramont, J Gastiaburu, et al.. (1993). Phase II trial of oxaliplatin: L-OHP® in patients with colorectal carcinoma (CRC) previously resistant to 5 fluoruracil (5 FU) and folinic acid (FA). European Journal of Cancer. 29. S96–S96. 1 indexed citations
14.
15.
Gramont, Aimery de, Christophe Louvet, Gustavo Gonzalez-Canali, et al.. (1992). Survival with Intraperitoneal Cisplatin in Advanced Ovarian Cancer after Second-Look Laparotomy. American Journal of Clinical Oncology. 15(1). 7–11. 9 indexed citations
16.
Gramont, Aimery de, C. Varette, Christophe Louvet, et al.. (1992). Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancer. European Journal of Cancer. 28(1). 53–58. 6 indexed citations
17.
Louvet, C., Aimery de Gramont, Bernard Nordlinger, et al.. (1991). High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer. Annals of Oncology. 2(3). 229–230. 37 indexed citations
18.
Bouslama, K., et al.. (1990). [Pulmonary toxoplasmosis in AIDS. Report of 3 cases].. PubMed. 141(5). 469–71. 2 indexed citations
19.
Gramont, Aimery de, C. Varette, Christophe Louvet, et al.. (1989). Survival after second-look laparotomy in advanced ovarian epithelial cancer. European Journal of Cancer and Clinical Oncology. 25(3). 451–457. 17 indexed citations
20.
Varette, C., Christophe Louvet, Gustavo Gonzalez-Canali, et al.. (1989). [Prognosis in ovarian cancer as a function of the results of the second-look laparatomy].. PubMed. 18(2). 222–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Pierre Lotz Breakdown of academic impact, for papers by D. Lepillé Breakdown of academic impact, for papers by P Dufour Breakdown of academic impact, for papers by P. Comella Breakdown of academic impact, for papers by Daniela Garavaglia Breakdown of academic impact, for papers by Edmonson Jh Breakdown of academic impact, for papers by Jennifer R. Scudiere Breakdown of academic impact, for papers by David D. Gibbs Breakdown of academic impact, for papers by J Genollá Breakdown of academic impact, for papers by Karen Theilade
Rankless by CCL
2026